These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
4. The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Terzolo M; Alì A; Osella G; Reimondo G; Pia A; Peretti P; Paccotti P; Angeli A Eur J Endocrinol; 2000 Jun; 142(6):611-7. PubMed ID: 10822224 [TBL] [Abstract][Full Text] [Related]
5. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. Vermeulen A; Kaufman JM; Giagulli VA J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841 [TBL] [Abstract][Full Text] [Related]
6. Involvement of serum dehydroepiandrosterone sulfate in erythropoietic activity. Harada K; Hanayama Y; Obika M; Itoshima K; Okada K; Otsuka F Aging Male; 2020 Dec; 23(5):756-763. PubMed ID: 30905228 [TBL] [Abstract][Full Text] [Related]
7. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma. Ozgen AG; Bayraktar F; Yilmaz C Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281 [TBL] [Abstract][Full Text] [Related]
8. Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample. Schunkert H; Hense HW; Andus T; Riegger GA; Straub RH Am J Hypertens; 1999 Nov; 12(11 Pt 1):1140-3. PubMed ID: 10604493 [TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. Laughlin GA; Barrett-Connor E J Clin Endocrinol Metab; 2000 Oct; 85(10):3561-8. PubMed ID: 11061502 [TBL] [Abstract][Full Text] [Related]
10. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys. Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181 [TBL] [Abstract][Full Text] [Related]
11. Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men. Rotter I; Kosik-Bogacka D; Dołęgowska B; Skonieczna-Żydecka K; Pawlukowska W; Laszczyńska M Aging Male; 2015; 18(4):249-55. PubMed ID: 26375874 [TBL] [Abstract][Full Text] [Related]
12. Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rezvani I; Garibaldi LR; Digeorge AM; Artman HG Pediatr Res; 1983 Feb; 17(2):131-4. PubMed ID: 6219334 [TBL] [Abstract][Full Text] [Related]
13. 'Exaggerated adrenarche' in children presenting with premature adrenarche. Likitmaskul S; Cowell CT; Donaghue K; Kreutzmann DJ; Howard NJ; Blades B; Silink M Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231 [TBL] [Abstract][Full Text] [Related]
14. Relationship between serum dehydroepiandrosterone sulfate, androstenedione, and sex hormones in men and women. Phillips GB Eur J Endocrinol; 1996 Feb; 134(2):201-6. PubMed ID: 8630520 [TBL] [Abstract][Full Text] [Related]
15. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956 [TBL] [Abstract][Full Text] [Related]
16. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumors before and after adrenal surgery. Tóth M; Rácz K; Varga I; Adleff V; Jakab C; Fútó L; Kiss R; Gláz E Eur J Endocrinol; 1997 Mar; 136(3):290-5. PubMed ID: 9100554 [TBL] [Abstract][Full Text] [Related]
17. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. Abbasi A; Duthie EH; Sheldahl L; Wilson C; Sasse E; Rudman I; Mattson DE J Am Geriatr Soc; 1998 Mar; 46(3):263-73. PubMed ID: 9514370 [TBL] [Abstract][Full Text] [Related]
18. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Birkenhäger-Gillesse EG; Derksen J; Lagaay AM Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622 [TBL] [Abstract][Full Text] [Related]
20. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Hautanen A; Mänttäri M; Manninen V; Tenkanen L; Huttunen JK; Frick MH; Adlercreutz H Atherosclerosis; 1994 Feb; 105(2):191-200. PubMed ID: 8003095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]